RETN and metabolic dysfunction-associated steatotic liver disease: The involvement of neuropeptide B in resistin secretion suggests that NPB may contribute to the modulation of pathophysiological processes dependent on resistin, such as insulin resistance, diabetes, atherosclerosis and cardiovascular diseases, autoimmune disease, asthma, and non-alcoholic fatty liver disease [135].